SEFIDENCE Trademark

Trademark Overview


On Wednesday, March 6, 2024, a trademark application was filed for SEFIDENCE with the United States Patent and Trademark Office. The USPTO has given the SEFIDENCE trademark a serial number of 98437143. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, March 12, 2025. This trademark is owned by Fulcrum Therapeutics, Inc.. The SEFIDENCE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy

Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Clinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development; Development of pharmaceutical preparations and medicines
sefidence

General Information


Serial Number98437143
Word MarkSEFIDENCE
Filing DateWednesday, March 6, 2024
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, March 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy
Goods and ServicesProviding information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Goods and ServicesClinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development; Development of pharmaceutical preparations and medicines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, March 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateWednesday, March 12, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateWednesday, March 12, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFulcrum Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameFulcrum Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Wednesday, March 6, 2024NEW APPLICATION ENTERED
Friday, July 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 19, 2024ASSIGNED TO EXAMINER
Wednesday, October 23, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 5, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 5, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 11, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, March 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 11, 2025TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, March 12, 2025ABANDONMENT - AFTER PUBLICATION
Sunday, May 11, 2025EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, March 12, 2025ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION